Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Email
Post
Print
Gene Uenishi, PhD (he/him/his)
Associate Director
GentiBio
Poster(s):
(226) Comprehensive Biomarker Strategy to Monitor GNTI-122, an Engineered Regulatory T Cell Therapy in Clinical Development to Treat Type 1 Diabetes
Saturday, April 18, 2026
2:30 PM - 3:30 PM
US ET
Email Gene
